Transcription of LCA Haemato-Oncology Clinical Guidelines
{{id}} {{{paragraph}}}
Example: biology
LCA Haemato-Oncology Clinical Guidelines
LCA Haemato-Oncology Clinical Guidelines Acute Leukaemias and Myeloid Neoplasms Part 4: Myeloproliferative Neoplasms April 2015. LCA Haemato-Oncology Clinical Guidelines . Contents 1. Introduction .. 4. 2. Clinical Features .. 6. Essential thrombocythaemia (ET) .. 6. Polycythaemia vera (PV) .. 6. Primary myelofibrosis (PMF) .. 6. 3. Referral Pathways .. 7. Children, teenagers and young adults .. 8. Teenagers and young adults .. 9. 4. Investigation and Diagnosis .. 10. Essential thrombocythaemia (ET) .. 10. Polycythaemia vera (PV) .. 12. Primary myelofibrosis (PMF) .. 15. Pathology .. 16. Imaging .. 16. 5. Risk Stratification .. 17. Essential thrombocythaemia (ET) .. 17. Polycythaemia vera (PV) .. 17. Primary myelofibrosis (PMF) .. 18. 6. Patient Information/Support.
LCA HAEMATO-ONCOLOGY CLINICAL GUIDELINES 4 1. Introduction Myeloproliferative neoplasms (MPN) conditions include essential thrombocythaemia (ET), polycythaemia
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: